Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

ME

23andMe Holding Co

Dec 13 • 04:00PM ET

3.35

Dollar change +0.02
Percentage change 0.60	%

Healthcare • Diagnostics & Research • USA • NASD

Peers: ILMN GH CRSP EXAS CDNA BGNE NTLA BEAM BMRN SRPT

| Held by: VTI VXF VHT PRFZ FESM ONEQ ITOT BIB IBBQ RFLR

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-25.27	Insider Own	91.36%	Shs Outstand	17.51M	Perf Week	-17.28%
Market Cap	92.12M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	16.02M	Perf Month	-21.18%
Income	-615.31M	PEG	-	EPS next Q	-	Inst Own	1.57%	Short Float	5.93%	Perf Quarter	-51.05%
Sales	193.26M	P/S	0.48	EPS this Y	-	Inst Trans	-14.99%	Short Ratio	2.84	Perf Half Y	-57.74%
Book/sh	3.95	P/B	0.85	EPS next Y	-	ROA	-109.86%	Short Interest	0.95M	Perf Year	-80.84%
Cash/sh	4.66	P/C	0.72	EPS next 5Y	-	ROE	-169.23%	52W Range	2.65 - 20.40	Perf YTD	-81.66%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-17.81%	ROI	-374.39%	52W High	-83.58%	Beta	1.15
Dividend TTM	-	Quick Ratio	1.10	Sales past 5Y	-22.63%	Gross Margin	33.17%	52W Low	26.18%	ATR (14)	0.39
Dividend Ex-Date	-	Current Ratio	1.20	EPS Y/Y TTM	-575.77%	Oper. Margin	-140.08%	RSI (14)	40.69	Volatility	8.94% 12.85%
Employees	582	Debt/Eq	0.70	Sales Y/Y TTM	-28.47%	Profit Margin	-318.39%	Recom	2.00	Target Price	8.40
Option/Short	Yes / Yes	LT Debt/Eq	0.61	EPS Q/Q	26.94%	Payout	-	Rel Volume	0.42	Prev Close	3.33
Sales Surprise	-	EPS Surprise	-	Sales Q/Q	-11.86%	Earnings	Nov 12 BMO	Avg Volume	334.94K	Price	3.35
SMA20	-1.63%	SMA50	-23.54%	SMA200	-55.89%	Trades		Volume	141,299	Change	0.60%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-29-22	Initiated	Berenberg	Buy	$7
Sep-22-22	Initiated	Cowen	Outperform	$6
Nov-15-21	Downgrade	Citigroup	Buy → Neutral	$12 → $13
Aug-17-21	Initiated	Credit Suisse	Outperform	$13
Jul-12-21	Initiated	Citigroup	Buy	$14

Dec-10-24 02:47AM	Whats next for 23andMe? (Pharma Voice)
Nov-21-24 04:23PM	Do Redditors Think That 23andMe Holding Co. (ME) Has a Big Upside Potential? (Insider Monkey)
Nov-20-24 07:30AM	23andMe and Mirador Therapeutics Enter Into Strategic Research Collaboration to Advance Miradors Precision Medicines for Immunology & Inflammation (GlobeNewswire) -8.16%
07:30AM	23andMe and Mirador Therapeutics Enter Into Strategic Research Collaboration to Advance Mirador's Precision Medicines for Immunology and Inflammation (GlobeNewswire)
Nov-13-24 07:14AM	23andMe to lay off more than 200 employees amid business struggles (MedTech Dive) -9.77%
02:07AM	Loading…
02:07AM	23andMe Holding Co (ME) Q2 2024 Earnings Call Highlights: Navigating Challenges with Strategic ... (GuruFocus.com)
Nov-12-24 11:57PM	Q2 2024 23andMe Holding Co. Earnings Call (Thomson Reuters StreetEvents)
03:47PM	23andMe is falling apart (Quartz)
02:14PM	23andMe cuts 40% of its workforce (Fox Business)
01:29PM	Struggling Genetic Testing Company 23andMe To Lay Off 40% Of Its Workforce, Discontinues All Therapeutic Programs (Benzinga)
01:14PM	After its entire board resigned overnight, 23andMe will cut over 200 employees and its cancer research in an urgent bid to nurse the company back to health (Fortune)
12:12PM	23andMe cuts 40% of its workforce and discontinues therapeutics division (Associated Press Finance)
10:12AM	Whats happening with 23andMe? Mass layoffs and restructuring are the latest blow for the embattled DNA-testing company (FastCompany)
09:52AM	23andMe Lays Off 40% of Staff, Shuts Drug Development Business (The Wall Street Journal)
07:30AM	23andMe Reports Second Quarter Fiscal Year 2025 Financial Results (GlobeNewswire)
06:55PM	Loading…
Nov-11-24 06:55PM	23andMe cuts 40% of its workforce, discontinues all therapy programs (CNN Business)
06:20PM	23andMe to Cut Workforce by 40%, Discontinues Therapeutics Pipeline (The Wall Street Journal)
05:30PM	23andMe Announces Business Restructuring to Streamline Operations, Reduce Costs and Position Company for the Future (GlobeNewswire)
Nov-07-24 05:54PM	CORRECTION - 23andMe to Report Q2 FY2025 Financial Results (GlobeNewswire)
07:30AM	23andMe to Report Q2 FY2025 Financial Results (GlobeNewswire)
Oct-31-24 09:55AM	23andMe turns to CFOs to fill director roles after mass board exit (CFO Dive)
07:34AM	23andMe appoints three former CFOs as new directorsafter the previous board all resigned (Fortune)
Oct-30-24 05:00PM	23andMe Regains Compliance With Nasdaq Listing Requirements (GlobeNewswire)
Oct-29-24 07:30AM	23andMe Appoints Three New Independent Directors to Board (GlobeNewswire)
Oct-28-24 12:27PM	Ancestry Says a 23AndMe Takeover Would Raise Antitrust Issues (Bloomberg)
Oct-25-24 05:00AM	Ozempic and Alzheimer's, 23andMe's crisis, and Novo Nordisk wants a crackdown: Pharma news roundup (Quartz)
Oct-24-24 03:34PM	The crisis at 23andMe, explained (Quartz)
Oct-22-24 10:54AM	ASML's Latest Chapter in the Semiconductor Story (Motley Fool)
Oct-21-24 09:03PM	SC US (TTGP), LTD. Acquires New Stake in 23andMe Holding Co (GuruFocus.com)
11:22AM	Explainer: 23andme is about to collapse what happens to all that DNA data? (Medical Device Network)
11:10AM	Loading…
Oct-18-24 11:10AM	23andMe CEO says she can 'land this plane' after the entire board resigns (Quartz)
06:53AM	Behind the scenes at 23andMe, questions about a star CEO (Fortune)
Oct-17-24 04:05PM	23andMe Introduces New Feature Helping African Americans Trace Their Roots to Post Slavery Communities in the South (GlobeNewswire) -8.05%
12:36PM	23andMes entire board resigned on the same day. Founder Anne Wojcicki still thinks the startup is savable (Fortune)
Oct-16-24 12:26PM	Founder Anne Wojcicki races to rescue 23andMe (Financial Times)
08:15AM	23andMe Announces Completion of 1-for-20 Reverse Stock Split (GlobeNewswire)
Oct-11-24 08:15AM	23andMe Announces 1-for-20 Reverse Stock Split (GlobeNewswire)
Oct-08-24 07:00AM	23andMe Announces Mathew Knowles as New Brand Ambassador (GlobeNewswire) -6.16%
Oct-07-24 10:41AM	Millions urged to delete data from mail-order DNA test maker (The Telegraph) +6.21%
Oct-05-24 05:02AM	How to delete your DNA data from 23andMe (Fortune)
Oct-02-24 12:44PM	Legal Battle Brews Over 23andMe's Customer Data Breach Settlement And Arbitration Claimants (Benzinga) +5.23%
Oct-01-24 05:09AM	23andMe no longer open to third-party takeover bids - filing (Investing.com) +6.19%
Sep-30-24 06:11PM	23andMe CEO Wojcicki no longer open to third-party takeover proposals, filing shows (Reuters) +18.16%
Sep-25-24 07:30AM	23andMe Launches New Genetic Report on Likelihood of Frequent Emotional Eating (GlobeNewswire) -7.03%
Sep-24-24 09:30AM	Barrack, Rodos & Bacine Is Investigating 23andMe Holding Co. (GlobeNewswire)
Sep-23-24 11:45AM	Barrack, Rodos & Bacine Is Investigating 23andMe Holding Co. (GlobeNewswire)
11:43AM	23andMe Board Quits As CEO Of DNA Testing Company Plans To Go Private (Black Enterprise)
Sep-20-24 06:00AM	What happened to 23andMe? (CNN Business)
Sep-19-24 04:50PM	23andMe directors resign as the CEO of the genetic-testing company seeks to take it private (Associated Press Finance)
12:34PM	How 23andMe Went From Market Darling to Losing Its Entire Board (Barrons.com)
11:25AM	Wolf Popper LLP is Investigating Whether the Offer to Acquire 23andMe Holding Co. By Its Controlling Shareholder Is Fair to the Minority Shareholders (GlobeNewswire)
07:37AM	23andMes independent board directors resign (MedTech Dive)
Sep-18-24 03:29PM	23andMe Board Resigns in New Blow to DNA-Testing Company (The Wall Street Journal)
12:14PM	Every single member of the board just resigned from DNA tester 23andMe (Fortune)
10:47AM	Tupperware, UAW-Stellantis, 23andme: 3 Stories In Focus (Yahoo Finance Video)
08:51AM	Independent Board Members Of Penny Stock 23andMe Resign, Call Out CEO Anne Wojcicki For Not 'Actionable Proposal' Despite Ample Time (Benzinga)
03:51AM	Landmark Fed decision in focus, futures edge higher - what's moving markets (Investing.com)
Sep-17-24 05:28PM	23andMe independent directors quit board over unsatisfactory buyout plan from CEO (Reuters)
04:26PM	Independent Directors of 23andMe Resign from Board (GlobeNewswire)
Sep-15-24 03:00AM	23andMe Therapeutics Announces Positive In Vivo Results for 23ME-01473, a Dual-Mechanism ULBP6-Targeting Antibody Currently in a Phase 1 Trial (GlobeNewswire)
03:00AM	23andMe Therapeutics Announces Phase 2 Results for Two Additional Cancer Cohorts and Correlative Biomarker Data from 23ME-00610 Study (GlobeNewswire)
Sep-13-24 12:41PM	23andMe settles data breach lawsuit for $30 million (Reuters)
Sep-12-24 04:05PM	One of the Largest and Most Diverse Studies on Sickle Cell Trait and Blood Clots Reveals Findings That Impact All Populations (GlobeNewswire) +6.93%
Sep-11-24 06:06PM	23andMe CEO Wojcicki open to third-party takeover proposals for firm, filing shows (Reuters)
Sep-03-24 07:30AM	23andMe to Present Updates on Clinical Immuno-oncology Programs 23ME-00610 and 23ME-01473 at ESMO Congress 2024 (GlobeNewswire)
Aug-28-24 07:30AM	Lemonaid Health Now Offering GLP-1 Medication Through Weight Loss Membership Program (GlobeNewswire)
Aug-08-24 09:56PM	ME Stock Earnings: 23andMe Holding Beats EPS, Misses Revenue for Q1 2025 (InvestorPlace)
04:05PM	23andMe Reports First Quarter Fiscal 2025 Financial Results (GlobeNewswire)
Aug-02-24 08:28AM	23andMe board rejects CEO Wojcickis take-private proposal (MedTech Dive)
08:25AM	Genetic testing firm 23andMe rejects CEO's take-private offer (Reuters)
08:00AM	23andMe Special Committee responds to CEO's take-private proposal (GlobeNewswire)
Aug-01-24 08:01AM	23andMe CEO proposes to take company private (MedTech Dive)
08:00AM	23andMe Announces CEO's Take-Private Proposal (GlobeNewswire)
Jul-31-24 06:52PM	23andMe CEO Wojcicki makes offer to take the firm private, filing shows (Reuters)
Jul-25-24 04:45PM	23andMe to Report Q1 FY2025 Financial Results (GlobeNewswire)
07:30AM	Twenty Lung Cancer Advocacy Organizations and 23andMe Come Together to Launch Lung Cancer Genetics Study to Help Advance Research (GlobeNewswire)
Jul-24-24 10:57AM	The 3 Best Personalized Nutrition Stocks to Buy Now (InvestorPlace)
Jul-11-24 06:45AM	3 High-Dividend Stocks to Buy if You Are Seeking Consistent Payouts (InvestorPlace)
Jul-01-24 10:23AM	23andMe and Nightingale partner to pilot blood-based risk detection panel (Medical Device Network)
Jun-28-24 07:00AM	23andMe And Nightingale Health Announce Strategic Collaboration To Pilot Blood Biomarker Panel (GlobeNewswire) -7.58%
Jun-11-24 06:00AM	3 Penny Stocks That Can Deliver Over 5,000% Upside by 2025: June Edition (InvestorPlace)
Jun-05-24 07:00AM	23andMe Launches New Genetic Report on Bipolar Disorder (GlobeNewswire)
Jun-04-24 12:48PM	Why 23andMe Stock Tumbled 10% on Tuesday (Motley Fool) -15.27%
07:00AM	23andMe and the Colorectal Cancer Alliance Collaborate to Help Advance Colorectal Cancer Research in the Black Community (GlobeNewswire)
Jun-03-24 08:00AM	23andMe Therapeutics Announces Positive Preliminary Phase 2 Safety and Efficacy Results for 23ME-00610, targeting CD200R1, at the 2024 ASCO Annual Meeting (GlobeNewswire)
May-29-24 08:00AM	Largest study on the LRRK2 variant leads to discoveries about health, ancestry, and history (GlobeNewswire) +11.95%
May-24-24 08:40AM	Q4 2024 23andMe Holding Co. Earnings Call (Thomson Reuters StreetEvents)
08:04AM	23andMe Holding Co. (NASDAQ:ME) Q4 2024 Earnings Call Transcript (Insider Monkey)
May-23-24 08:53PM	ME Stock Earnings: 23andMe Holding Beats EPS, Beats Revenue for Q4 2024 (InvestorPlace)
04:05PM	23andMe Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results (GlobeNewswire)
May-14-24 03:59PM	Sector Update: Health Care Stocks Rise in Late Afternoon Trading (MT Newswires) +15.46%
02:03PM	Sector Update: Health Care Stocks Ease in Tuesday Afternoon Trading (MT Newswires)
12:08PM	23andMe Unit Offers Petros Pharmaceuticals' Impotency Medication (MT Newswires)
09:15AM	Petros Pharmaceuticals Launches U.S. Distribution of Prescription ED Medication STENDRA Through Recently Announced Collaboration With Lemonaid Health, a Subsidiary of 23andMe (ACCESSWIRE)
07:00AM	Lemonaid Health Now Offers Prescription ED Medication STENDRA Through Collaboration with Petros Pharmaceuticals (GlobeNewswire)
May-10-24 04:36PM	Struggling 23andMe Granted Extension to Revive Stock Price (Bloomberg) +6.35%
May-09-24 04:50PM	23andMe to Report Q4 and Full Year FY2024 Financial Results (GlobeNewswire) +5.66%
Apr-25-24 09:44PM	7 Best Sites Like Ancestry.com to Research Your Family History (Insider Monkey)
Apr-24-24 04:05PM	23andMe to Present Preliminary Efficacy and Biomarker Data for 23ME-00610 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting (GlobeNewswire) -5.39%
Apr-23-24 05:21AM	This Technology Company Is Being Acquired at a Shocking 207% Premium -- and These 2 Stocks Could Be Next (Motley Fool) +7.23%

23andMe Holding Co. is a consumer genetics and research company, which engages in assisting people to access, understand, and benefit from the human genome. It operates through the Consumer and Research Services, and Therapeutics segments. The Consumer and Research Services segment consists of Personal Genome Service, Telehealth Business, and Research Services. The Therapeutics segment focuses on the genetic insights of genetic and phenotypic information. The company was founded by Anne E. Wojcickiin 2006 and is headquartered in Sunnyvale, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Sequoia Grove UK LP	Affiliate	Nov 15 '24	Proposed Sale	3.82	3,615	13,809		Nov 15 09:17 PM
Sequoia Grove II LLC	Affiliate	Nov 15 '24	Proposed Sale	3.82	321,219	1,227,057		Nov 15 09:10 PM
Taylor Peter J.	Former Board Member	Nov 15 '24	Proposed Sale	3.82	18,807	71,842		Nov 15 04:03 PM
HIBBS KATHY L	Chief Administrative Officer	May 02 '24	Option Exercise	0.42	38,551	16,191	1,290,866	May 06 04:56 PM
HIBBS KATHY L	Chief Administrative Officer	May 02 '24	Sale	0.49	38,551	19,048	1,252,315	May 06 04:56 PM
HIBBS KATHY L	Chief Administrative Officer	Apr 18 '24	Option Exercise	0.42	38,548	16,190	1,290,863	Apr 19 04:20 PM
HIBBS KATHY L	Chief Administrative Officer	Apr 18 '24	Sale	0.47	38,548	18,148	1,252,315	Apr 19 04:20 PM
HIBBS KATHY L	Chief Administrative Officer	Apr 04 '24	Option Exercise	0.42	38,548	16,190	1,290,863	Apr 05 04:14 PM
HIBBS KATHY L	Chief Administrative Officer	Apr 04 '24	Sale	0.50	38,548	19,282	1,252,315	Apr 05 04:14 PM
HIBBS KATHY L	Chief Administrative Officer	Mar 21 '24	Option Exercise	0.42	38,548	16,190	1,290,863	Mar 22 07:22 PM
HIBBS KATHY L	Chief Administrative Officer	Mar 21 '24	Sale	0.46	38,548	17,894	1,252,315	Mar 22 07:22 PM
HIBBS KATHY L	Chief Administrative Officer	Mar 07 '24	Option Exercise	0.42	38,548	16,190	1,290,863	Mar 11 04:09 PM
HIBBS KATHY L	Chief Administrative Officer	Mar 07 '24	Sale	0.53	38,548	20,430	1,252,315	Mar 11 04:09 PM
HIBBS KATHY L	Chief Administrative Officer	Feb 22 '24	Option Exercise	0.42	38,548	16,190	1,278,375	Feb 23 05:09 PM
HIBBS KATHY L	Chief Administrative Officer	Feb 22 '24	Sale	0.61	38,548	23,325	1,239,827	Feb 23 05:09 PM
HIBBS KATHY L	Chief Administrative Officer	Feb 15 '24	Option Exercise	0.42	38,548	16,190	1,318,897	Feb 16 04:47 PM
HIBBS KATHY L	Chief Administrative Officer	Feb 15 '24	Sale	0.78	38,548	30,210	1,280,349	Feb 16 04:47 PM
HIBBS KATHY L	Chief Administrative Officer	Jan 25 '24	Option Exercise	0.42	38,548	16,190	1,318,897	Jan 26 08:24 PM
HIBBS KATHY L	Chief Administrative Officer	Jan 25 '24	Sale	0.73	38,548	27,997	1,280,349	Jan 26 08:24 PM
HIBBS KATHY L	Chief Administrative Officer	Jan 11 '24	Option Exercise	0.42	38,548	16,190	1,318,897	Jan 12 06:51 PM
HIBBS KATHY L	Chief Administrative Officer	Jan 11 '24	Sale	0.72	38,548	27,581	1,280,349	Jan 12 06:51 PM
HIBBS KATHY L	Chief Administrative Officer	Dec 28 '23	Option Exercise	0.42	38,548	16,190	1,318,897	Dec 29 04:04 PM
HIBBS KATHY L	Chief Administrative Officer	Dec 28 '23	Sale	0.93	38,548	35,904	1,280,349	Dec 29 04:04 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ME

23andMe Holding Co

Upgrade your FINVIZ experience